ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
ANI Pharmaceuticals (Nasdaq: ANIP) announced its participation in the 36th Annual Piper Sandler Healthcare Conference. President and CEO Nikhil Lalwani and CFO Stephen Carey will host a fireside chat on Wednesday, December 4, 2024, at 3pm EST in New York City.
The event will be available via live webcast and can be accessed through the company's website at www.anipharmaceuticals.com in the Investors section under Events and Presentations. A replay will remain accessible for 90 days following the presentation.
ANI Pharmaceuticals (Nasdaq: ANIP) ha annunciato la sua partecipazione alla 36ª Conferenza Sanitaria Annuale Piper Sandler. Il Presidente e CEO Nikhil Lalwani e il CFO Stephen Carey condurranno una conversazione informale mercoledì 4 dicembre 2024, alle 15:00 EST a New York City.
L'evento sarà disponibile tramite webcast dal vivo e potrà essere accessibile attraverso il sito web dell'azienda all'indirizzo www.anipharmaceuticals.com nella sezione Investitori sotto Eventi e Presentazioni. Una registrazione sarà disponibile per 90 giorni dopo la presentazione.
ANI Pharmaceuticals (Nasdaq: ANIP) anunció su participación en la 36ª Conferencia Anual de Salud Piper Sandler. El Presidente y CEO Nikhil Lalwani y el CFO Stephen Carey llevarán a cabo una charla informal el miércoles 4 de diciembre de 2024, a las 3pm EST en Nueva York.
El evento estará disponible a través de una transmisión en vivo y se podrá acceder a través del sitio web de la empresa en www.anipharmaceuticals.com en la sección de Inversores bajo Eventos y Presentaciones. Una repetición estará disponible durante 90 días después de la presentación.
ANI Pharmaceuticals (Nasdaq: ANIP)는 제36회 파이퍼 샌들러 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 사장 겸 CEO 니킬 랄와니와 CFO 스티븐 캐리가 2024년 12월 4일 수요일 오후 3시 EST에 뉴욕시에서 파이어사이드 채팅을 진행할 예정입니다.
행사는 라이브 웹캐스트를 통해 제공되며, 회사의 웹사이트 www.anipharmaceuticals.com에서 투자자 섹션의 이벤트 및 프레젠테이션 아래에서 접근할 수 있습니다. 프레젠테이션 후 90일 동안 다시보기 가능할 것입니다.
ANI Pharmaceuticals (Nasdaq: ANIP) a annoncé sa participation à la 36ème Conférence Annuelle Piper Sandler sur la Santé. Le président et CEO Nikhil Lalwani et le CFO Stephen Carey animeront une discussion informelle le mercredi 4 décembre 2024 à 15h EST à New York.
L'événement sera disponible en direct via un webcast et pourra être consulté sur le site de l'entreprise à l'adresse www.anipharmaceuticals.com dans la section Investisseurs sous Événements et Présentations. Un replay sera accessible pendant 90 jours après la présentation.
ANI Pharmaceuticals (Nasdaq: ANIP) gab seine Teilnahme an der 36. jährlichen Piper Sandler Gesundheitskonferenz bekannt. Präsident und CEO Nikhil Lalwani und CFO Stephen Carey werden am Mittwoch, den 4. Dezember 2024, um 15:00 Uhr EST in New York City ein Fireside-Chat moderieren.
Die Veranstaltung wird über einen Live-Webcast verfügbar sein und kann über die Unternehmenswebsite www.anipharmaceuticals.com im Bereich Investoren unter Veranstaltungen und Präsentationen aufgerufen werden. Eine Aufzeichnung wird 90 Tage nach der Präsentation verfügbar sein.
- None.
- None.
PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host a fireside chat at the 36th Annual Piper Sandler Healthcare Conference on Wednesday, December 4, 2024 at 3pm EST in NYC.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch ANI Pharmaceuticals' (ANIP) Piper Sandler Conference presentation?
How long will ANI Pharmaceuticals' (ANIP) Piper Sandler Conference webcast be available?
Who will represent ANI Pharmaceuticals (ANIP) at the 2024 Piper Sandler Healthcare Conference?
